AzTrials
AzTrials

Emotion DysregulationREACHNCT06963801

DBT-P Treatment Study

A study testing Moms2B and DBT-P in people with Emotion Dysregulation, run by Duke University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to find out if improving emotion regulation skills use during pregnancy reduces maternal stress and improves heart rate. The main questions it aims to answer are: Does improving emotion regulation skills during pregnancy reduce stress and improve the ability to cope? How is a participant's… Read more about this study

Who is it for?
Ages 18 to 45 years, women only
Conditions the study is for
Emotion Dysregulation
What is being tested?
Moms2B and DBT-P
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
6 Jun 2025to 19 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Emotion dysregulation score of 88 or above
  • At least 12 weeks pregnant
  • Singleton Pregnancy
  • Fluent in English

Who cannot join

  • Active psychosis
  • Drug or alcohol use disorder during pregnancy
  • High risk of an imminent suicide attempt
  • Significant health complications (e.g., cancer)
  • Illiterate and/or unable to independently complete and comprehend written measures

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Alicia Holloway contact

(919) 684-1333

adh60@duke.edu

United States1 site, 1 recruiting
  • Duke University

    Durham, North Carolina, 27705

    Alicia Holloway, (919) 684-1333, adh60@duke.edu

    Janea Cato, (919) 684-3251, janea.cato@duke.edu

    Recruiting

Other trials in United States

About this study

Official title: Developing Pregnancy-specific Dialectical Behavior Therapy Skills to Promote Multigenerational Mental Health

The goal of this study is to find out if improving emotion regulation skills use during pregnancy reduces maternal stress and improves heart rate.

The main questions it aims to answer are:

Read more
  • Does improving emotion regulation skills during pregnancy reduce stress and improve the ability to cope?
  • How is a participant's heart rate affected by their ability to control their emotions during pregnancy?

Researchers will test the hypothesis that dialectical behavior therapy skills groups (DBT-P) will improve emotion regulation skills use as well as heart rate.

Participants will:

  • Visit the clinic for 3 sessions at the beginning, middle and end of their pregnancy.
  • Compete surveys and interviews asking about their thoughts, feelings and how they cope with emotions.
  • Have their heart rate taken.
  • If assigned to the investigational group, they will complete weekly remote emotion regulation skills groups for 10 weeks and complete daily diary cards that ask about mood and any thoughts of self-harm.
  • Optional Element: Complete a 20-30min infant neurobehavior exam (NNNS exam) after delivery.
Read the detailed description

The investigators' observational research with mothers with emotion dysregulation and their infants shows that poor emotion regulation skill use is a mechanism that likely confers risk for self-injurious thoughts and behaviors, depression, and anxiety in the mother and neurobehavioral and co-regulatory challenges in the infant. Emotion dysregulation is an impairing, early-emerging, transdiagnostic vulnerability factor that has intergenerational implications. Treatments have been developed for non-pregnant adults with emotion dysregulation but these are costly, time-intensive, and do not address the unique needs of pregnant people, highlighting an unmet therapeutic need. Through this innovative intervention, researchers will test whether targeting emotion regulation skills use during pregnancy will both improve postpartum emotion regulation, newborn neurobehavior, and mother-infant co-regulation. Early identification of the mechanisms implicated in risk. The researchers will deliver 10 weeks of DBT skills classes selected and adapted to meet the unique needs of pregnancy (DBT-P). The goal of this work is to improve perinatal mental health trajectories.

The premise of this study-that improving emotion regulation in pregnancy may disrupt intergenerational transmission of psychopathology-is informed by our research over the past two decades, including several NIH awards (R01MH119070, R01MH132210, R01DA049755, R21MH1090777, F31MH074196). The investigator' data reveal that maternal emotion dysregulation confers risk for mother. The research also shows that resting respiratory sinus arrhythmia (RSA), a physiological index of emotion dysregulation, can be improved via intervention in non-pregnant adults. The investigators propose that DBT-P will increase emotion regulation skills use or increase RSA in the mother (target engagement) leading to significant reductions in her emotion dysregulation prior to birth.

The primary study objectives are to recruit 100 pregnant women with high emotion dysregulation to receive either: (1) dialectical behavior therapy skills groups or an Assessment only control; and (2) to evaluate whether the treatment improved emotion regulation skills use as well as respiratory sinus arrhythmia.

Being tested
Moms2B, DBT-P
Keywords
Emotion dysregulation, Pregnancy, Maternal health, RSA, Coping, Stress, DBT-P, Moms2B

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Moms2BBehavioural

    An established group-based pregnancy program focusing on improving nutrition, social, and medical support.

  • DBT-PBehavioural

    An emotional skills group where emotion regulation skills are taught in the context of the pregnancy and expected life with an infant.

Study groups in NCT06963801
Study groupRoleWhat they receive
Moms2BActive comparatorMoms2B is an established group-based intervention for pregnant women focused on enhancing social support and improving nutrition. Participants will receive 3 sessions using this established assessment only treatment plan as well as complete surveys and clinical interviews assessing stress, coping strategies and emotions. Resting heart rate data as well as heart rate data post stimulus to be assessed.
Receives: Behavioral: Moms2B
DBT-PExperimentalDBT-P is a Dialectical Behavior Therapy skills group adapted for pregnant people. Participants will receive weekly DBT-P group sessions for 10 weeks where they learn skills to: (1) enhance self-awareness; (2) improve ability to manage crises; (3) decrease negative emotions and increase positive emotions; (4) improve your relationships and self-respect; they will also complete homework as part of the group participation as well as complete daily diary cards that will ask about their mood and any thoughts of self-harm . Completion of surveys and clinical interviews assessing stress, coping strategies and emotions are included; resting heart rate data as well as heart rate data post stimulus to be assessed.
Receives: Behavioral: Moms2B; Behavioral: DBT-P

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difficulties in Emotion Regulation Scale (DERS)

    The DERS is a 36-item measure scored on a 5-point Likert Scale. DERS scores range from 36-180 and enrollment in this study requires a baseline total DERS score of ≥88 which indicate greater difficulties in emotion regulation.

    Measured: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)

  2. Respiratory Sinus Arrhythmia (RSA)

    RSA is a peripheral index of parasympathetic nervous system influences on cardiac activity and is measured as the variability in heart rate that coincides with respiration.

    Measured: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)

Secondary outcomes (10)
  1. Percent of participation

    Feasibility of the assessment schedule will include the percent of participation at all timepoints.

    Measured: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)

  2. Percent of missing data

    Feasibility of the assessment schedule will include the percent of missing data at all time points.

    Measured: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)

  3. Recruitment rates

    Feasibility of the intervention will be assessed by evaluating recruitment rates.

    Measured: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)

  4. Reasons for refusal

    Feasibility of the intervention will be assessed by evaluating reasons for refusal. Collection of reasons for refusal to be obtained via subject self-report at each individual timepoint; expected attendance for 85% of sessions.

    Measured: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)

  5. Intervention adherence

    Feasibility of the intervention will be assessed by evaluating intervention adherence. Weekly assessment of intervention adherence conducted by clinicians based on subject completion of required homework assignments, daily diary entries and group session attendance.

    Measured: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)

  6. Number of women who complete all sessions

    Feasibility will be assessed by how many women completed all sessions.

    Measured: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)

  7. Number of interventionists who can self-monitor for fidelity, assessed by watching segments of video-recorded sessions

    Feasibility will be assessed by whether the interventionist can self-monitor for fidelity.

    Measured: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)

  8. Participation rates

    Acceptability will be assessed by participation rates.

    Measured: Post-treatment (Week 10)

  9. Participant satisfaction with the intervention assessed by the Client Satisfaction Questionnaire

    Acceptability will be assessed by measuring participant satisfaction with the intervention (including completion of the intervention) using the Client Satisfaction Questionnaire. Scores are summed across items once. Items 2, 4, 5, and 8 are reverse scored. Total scores range from 8 to 32, with the higher number indicating greater satisfaction.

    Measured: Post-treatment (Week 10)

  10. Telehealth acceptability specific to DBT skills training

    A 41-item original survey developed by DBT experts in the United States and Australia to measure participants' satisfaction with DBT delivered through telehealth. Items designed to assess relevance of care experience on a 5-pt scale from Not Relevant to Very Relevant. Responses anonymized and qualitative free-text fields provided for recommendations and comments for changes or improvements.

    Measured: Post-treatment (Week 10)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2025
  2. Study start6 Jun 2025
  3. Primary completion5 Mar 2027 (estimated)
  4. Study completion19 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two groups: control group is assessment only and treatment group is DBT-P group sessions (emotional skills regulation groups). Groups stratified based on gestational age (14-20 weeks vs 21-27 weeks) as well as race and ethnicity.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06963801
Sponsor's protocol ID
Pro00116252
Other IDs
R61MH138444
Acronym
REACH
Status last verified
Apr 2026
First submitted
30 Apr 2025
Last updated
6 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Moms2B and DBT-P in people with Emotion Dysregulation, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Janea Cato ((919) 684-3251, janea.cato@duke.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difficulties in Emotion Regulation Scale (DERS) (time frame: Baseline (Week 0), mid-treatment (Week 5), and post-treatment (Week 10)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in